Cargando…
Induction of Cross-Reacting Antibodies Against the COVID-19 by BCG Vaccination in the Mouse Model
It was reported that tuberculosis and BCG vaccination are potential tools for reducing the burden of COVID-19, mainly through the non-specific trained immunity. We have investigated whether BCG vaccination is able to induce cross-reacting antibodies against the SARS-CoV-2. We have tested the induced...
Autores principales: | Rahali, Nadia, Bahloul, Chokri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362411/ https://www.ncbi.nlm.nih.gov/pubmed/35907089 http://dx.doi.org/10.1007/s00284-022-02971-w |
Ejemplares similares
-
Improvement of Thermal Stability of BCG Vaccine
por: Sefidi, Fatemeh Jahanbakhsh, et al.
Publicado: (2017) -
Natural unblinding of BCG vaccination trials
por: Szigeti, Reka, et al.
Publicado: (2021) -
Currently available intravenous immunoglobulin contains antibodies reacting against severe acute respiratory syndrome coronavirus 2 antigens
por: Díez, José-María, et al.
Publicado: (2020) -
BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis
por: Tomita, Yusuke, et al.
Publicado: (2020) -
OX130 Monoclonal Antibody Recognizes Human SIRPβ1 but Cross-Reacts on SIRPα from One Allele
por: Hatherley, Deborah, et al.
Publicado: (2016)